Menu Contents

PRODUCTS

A guide to all Boryung Pharmaceutical’ products.

  • Kanarb

    Kanarb [Fimasartan] (Oral Solid, Filmcoated Tablet)

    Strength
    60mg, 120mg
    Indication
    Angiotensin II Receptor Blocker
    Shelf Life
    36
    Packaging Sizes
    30tabs
    Kanarb Plus

    Kanarb Plus [Fimasartan 60mg Hydrochlorothiazide (USP), Fimasartan 120mg Hydrochlorothiazide (USP) 12.50 mg 12.50 mg,] (Oral Solid, Filmcoated Tablet)

    Indication
    Angiotensin II Receptor Blocker
    Shelf Life
    36
    Packaging Sizes
    30tabs
    Dukarb

    Dukarb [Fimasartan 60 mg Amlodipine(EP) 5mg, Fimasartan 60 mg Amlodipine(EP) 10mg] (Oral Solid, Filmcoated Tablet)

    Indication
    Angiotensin II Receptor Blocker
    Shelf Life
    24
    Packaging Sizes
    30tabs
    Dukaro

    Dukaro [Fimasartan+Amlodipine+Rosuvastatin (Oral Solid, Filmcoated Tablet) ]

    Strength
    30/5/5mg, 30/5/10mg, 60/5/5mg, 60/5/10mg
    Indication
    Angiotensin II Receptor Blocker
    Shelf Life
    30M
    Packaging Sizes
    30 Tabs
    Akarb

    Akarb [Fimasartan+ Atorvastatin (Oral Solid, Filmcoated Tablet) ]

    Strength
    30/10mg, 30/20mg, 60/10mg, 60/20mg
    Indication
    Angiotensin II Receptor Blocker
    Shelf Life
    36M
    Packaging Sizes
    30 Tabs
  • V.C.S Inj.

    V.C.S Inj. [Vincristine Sulphate ]

    Strength
    1mg, 2mg
    Indication
    Anticancer
    Shelf Life
    24M
    Packaging Sizes
    1 Vial
    Velkin Inj.

    Velkin Inj. [Bortezomib trimer ]

    Strength
    2.5mg, 3.5mg
    Indication
    Anticancer
    Shelf Life
    36M
    Packaging Sizes
    1 Vial
    Alimxid Inj.

    Alimxid Inj. [Pemetrexed disodium 2.5 hydrate ]

    Strength
    500mg
    Indication
    Anticancer
    Shelf Life
    36M
    Packaging Sizes
    1 Vial
    Effcil Inj.

    Effcil Inj. [5 Fluorouracil ]

    Strength
    500mg
    Indication
    Anticancer
    Shelf Life
    24M
    Packaging Sizes
    10 Vials
    Oxalitin

    Oxalitin [Oxaliplatin] (inj)

    Strength
    50mg,100mg
    Indication
    Anticancer
    Shelf Life
    36,24
    Neoplatin

    Neoplatin [Carboplatin] (inj)

    Strength
    150mg, 450mg
    Indication
    Anticancer
    Shelf Life
    24
    EP mycin

    EP mycin [Epriubicin] (inj)

    Strength
    10mg,50mg
    Indication
    Anticancer
    Shelf Life
    36
    AD mycin

    AD mycin [Doxorubicin] (inj)

    Strength
    10mg,50mg
    Indication
    Anticancer
    Shelf Life
    24
  • GelfosM

    GelfosM [ALPO4, Mg Hydroxide, Simethicone] (sachet)

    Strength
    20g/sachet X 4s
    Indication
    Hypergastric acidity, heartburn, gastric and duodenal ulcer, gastritis, gastralgia, nausea
    Shelf Life
    24
    Packaging Sizes
    4sachets/Box
  • Marketed API

    Marketed API
    API Therapeutic Area Spec. Polymorphic Form CTD Batch Size GMP
    Dasatinib Anticancer In-house N-6 JMF 5Kg KGMP
    Fexofenadine HCl Antihistamines USP + In-house Type I JMF 400Kg KGMP/PMDA
    Alacepril Cardiovascular JP - JMF 150Kg KGMP/PMDA
    Fimasartan potassium 3H2O Cardiovascular In-house - NMD 300Kg KGMP/EUGMP
    Pitavastatin Ca Cardiovascular JP Modified Type A JMF 35Kg KGMP/PMDA
    Aripiprazole Nervous system In-house Type II JMF 20Kg KGMP/PMDA
    Tamsulosin HCl Urology EP - JMF 6Kg KGMP/PMDA

    Pipeline API

    Pipeline API
    API Therapeutic Area Filing Status
    Olaparib Anticancer Lab scale development until 2021
    Ezalutamide Anticancer Lab scale development until 2021
    Edoxaban Anticoagulant Pilot batch planned 2021
    Pilsicainide Cardiovascular PV batch planned 3Q, 2021
    Cilnidipine Cardiovascular PV completed
    Lafutidine Gastrointestinal PV completed
    Dapagliflozin Metabolism Pilot batch planned  3Q, 2021
    Empagliflozin Metabolism Lab scale development until 2021
    Brexpiprazole Nervous system Pilot batch planned 2022